Udvalget fandt, at fordelene ved Gliolan opvejer risiciene til synliggørelse af ondartet væv ved operation for ondartet gliom.
The Committee decided that Gliolan’ s benefits are greater than its risks for the visualisation of malignant tissue during surgery for malignant glioma.